CNS Pharmaceuticals, Inc.
CNSP · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Fisher Michal: Form 4
Insider disclosure · Filed · Report period 18 May 2026
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001729427 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CNSP on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2100 West Loop South, Suite 900, Houston, TX, 77027
- Incorporated in
- NV
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields